Drug delivery selective

K. Ulbrich, J. Cassidy and R. Duncan, Synthetic-polymers conjugated to monoclonal-antibodies — vehicles for tumor-targeted drug delivery. Select. Cancer Ther., 7,59-73 (1991). 

DOX, as EPI seems to form fewer amounts of ROS and secondary alcohol metabolite, (ii) encapsulation of anthracyclines in uncoated or pegylated liposomes that ensure a good drug delivery to the tumor but not to the heart, (iii) conjugation of anthracyclines with chemical moieties that are selectively recognized by the tumor cells, (iv) coadministration of dexrazoxane, an iron chelator that diminishes the disturbances of iron metabolism and free radical formation in the heart, and (v) administration of anthracyclines by slow infusion rather than 5-10 min bolus (Table 1). Pharmacological interventions with antioxidants have also been considered, but the available clinical studies do not attest to an efficacy of this strategy. 

Sterilization of the finished drug delivery formulation is an important consideration often overlooked in the early design of lactide/glycolide delivery systems. Aseptic processing and terminal sterilization are the two major routes of affording an acceptably sterile product. Both of these methods are suitable for products based on lactide/glycolide polymers if proper care is exercised in processing or selection of the treatment procedures. 

Chaubal, M. Application of drug delivery technologies in lead candidate selection and optimization. Drug Discov. Today 2004, 9, 603-609. 

There are many polymers which have been used as physical matrices for controlled delivery of drugs. In this paper, these polymers are separated into water-soluble, biodegradable, and nonbiodegradable materials. A description of each class of polymers is presented. Examples of polymers from each class that have been used as drug delivery matrices and the criteria for their selection are included in this general review. 

K. J. Widder and A. E. Senyei, Magnetic microsphere A vehicle for selective targeting of organs, in Methods of Drug Delivery (G. M. Ihler, ed.), Pergamon Press, New York, 1986, p. 39. 

Lee CP, RLA Devrueh, PL Smith. (1997). Selection of development candidates based on in vitro permeability measurements. Adv Drug Delivery Rev 23 47-62. 

The benefit of the LbL technique is that the properties of the assemblies, such as thickness, composition, and function, can be tuned by varying the layer number, the species deposited, and the assembly conditions. Further, this technique can be readily transferred from planar substrates (e.g., silicon and quartz slides) [53,54] to three-dimensional substrates with various morphologies and structures, such as colloids [55] and biological cells [56]. Application of the LbL technique to colloids provides a simple and effective method to prepare core-shell particles, and hollow capsules, after removal of the sacrificial core template particles. The properties of the capsules prepared by the LbL procedure, such as diameter, shell thickness and permeability, can be readily adjusted through selection of the core size, the layer number, and the nature of the species deposited [57]. Such capsules are ideal candidates for applications in the areas of drug delivery, sensing, and catalysis [48-51,57]. 

Rifaximin is broad-spectrum antibiotic, which covers many skin pathogens, whose lack of transcutaneous absorption has been well documented by both animal [8] and human [9] studies. On these grounds, a topical formulation (i.e. cream) containing 5% of the active compound was developed and tested in the treatment of pyogenic skin infections. Some open trials [20, 21] showed the efficacy and safety of the formulation and pointed out the lack of selection of resistant strains after topical application of rifaximin. In any event, drug delivery from the topical formulation is orders of magnitude higher than the... 

---